Insights on AI, medical research, and the future of scientific discovery.
Most AI assistants answer questions in a vacuum. Ours answers in the context of your entire research project.
Read more →
The forest plot is the most recognisable output of a meta-analysis - and one of the most frequently misread. Here is what the visual is actually telling you, and what it conceals.
Read more →
A hypothesis without a plan is an idea. A hypothesis with phased milestones, timelines, and go/no-go criteria is a project.
Read more →
When Bayer scientists tried to replicate preclinical oncology findings, they succeeded in fewer than a quarter of attempts. This is not an anomaly - it is a structural feature of how preclinical research is conducted and reported.
Read more →
A research tool that produces output you cannot use in your existing workflow is a tool you will stop using. Export matters more than features.
Read more →
Adaptive trials promise efficiency and flexibility - but they introduce complexity that can undermine the very rigour they are designed to preserve. Knowing when they add value is the question most sponsors skip.
Read more →
Data sovereignty is not a checkbox. It is an architectural decision. We built NousLab to work however your institution needs it to.
Read more →
Observational studies are the backbone of real-world evidence - and the source of most retractions. Getting the design right before data collection is the difference between credible findings and a desk reject.
Read more →
In most research teams, work is invisible until it is published. A shared research library makes ongoing work findable and reusable.
Read more →
Preprints accelerate scientific communication - but COVID-19 showed what happens when unreviewed findings become policy. The case for preprints is real, and so are the risks.
Read more →
Before you write a grant application, you need to find the right call. That search alone can take weeks. And then the writing starts.
Read more →
The studies that never reach PubMed - unpublished trials, internal reports, conference abstracts - can be decisive for the conclusions of a systematic review. Ignoring them is not a neutral choice.
Read more →Join leading pharmaceutical companies, hospitals, biotech labs, CROs, and research centers using NousLab to accelerate medical breakthroughs.
Schedule a DemoTalk to our team to learn about licensing options for your organization